Related Experiment Videos
Ribavirin administration to infants receiving mechanical ventilation
K M Outwater1, H C Meissner, M B Peterson
1Department of Pediatrics, New England Medical Center, Boston, MA.
Insights
Aerosolized ribavirin treatment was safely administered to 12 infants with severe bronchiolitis on mechanical ventilation. This study demonstrates a successful method for delivering the antiviral medication to critically ill infants.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Respiratory medicine
Background:
- Bronchiolitis is a common viral respiratory infection in infants, often leading to severe respiratory failure.
- Infants with underlying cardiac or pulmonary conditions are at higher risk for severe bronchiolitis and require mechanical ventilation.
- Antiviral therapy options for severe infant bronchiolitis remain limited.
Purpose of the Study:
- To evaluate the safety and efficacy of aerosolized ribavirin administration in infants with severe bronchiolitis requiring mechanical ventilation.
- To describe a specialized method for delivering aerosolized ribavirin to mechanically ventilated infants.
- To assess the feasibility of monitoring and managing patients during this treatment.
Main Methods:
- A cohort of 12 infants with severe bronchiolitis and respiratory failure on mechanical ventilation received aerosolized ribavirin.
- A specific administration protocol was developed, including timed circuit changes to prevent drug precipitation, frequent endotracheal suctioning, and continuous patient/ventilator monitoring.
- Treatment success and patient tolerance were the primary outcomes assessed.
Main Results:
- All 12 infants successfully completed the aerosolized ribavirin treatment.
- The developed administration and monitoring method effectively prevented circuit obstruction and allowed for safe drug delivery.
- No adverse events related to ribavirin administration were reported in the study cohort.
Conclusions:
- Aerosolized ribavirin can be safely and effectively administered to infants with severe bronchiolitis receiving mechanical ventilation.
- The specialized method for drug delivery and patient monitoring is crucial for successful treatment in this vulnerable population.
- This approach offers a potential therapeutic option for severe cases of infant bronchiolitis, particularly in high-risk infants.
Abstract:
Aerosolized ribavirin was administered to 12 infants with bronchiolitis who were receiving mechanical ventilation. All patients had a history of cardiac or pulmonary disease and developed severe respiratory failure during their infection. We developed a method for ribavirin administration and patient monitoring that included timed circuit valve and tubing changes to avoid obstruction by precipitated drug, frequent endotracheal tube suctioning, and constant observation of the patient and ventilator. All patients were successfully treated. We conclude that ribavirin can be safely administered to infants receiving mechanical ventilation.